Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2024.107 | The effect of Short Message Service interventions on promoting exercise adherence for patients with knee conditions |
Prof. ONG Michael Tim Yun Michael Tim-Yun ONG |
| 2025.402 | Surgical accuracy of open platform image‐based robotic‐assisted total hip arthroplasty | Prof. ONG Michael Tim Yun |
| 2013.248 | Tissue bank for the study of degenerative joint disease | Prof. ONG Michael Tim Yun |
| 2019.488 | The effect of whole body vibration therapy on increasing quadriceps strength prior to anterior cruciate ligament reconstruction |
Prof. ONG Tim Yun 王添欣 |
| 2021.328 | A Double-Blinded, Randomized-Controlled-Trial to Investigate the Effect of Pulsed Electromagnetic Field (PEMF) on Prehabilitation for Patients receiving Anterior Cruciate Ligament Reconstruction |
Prof. ONG Tim Yun 王添欣 |
| 2021.588 | Patients Undergo Bilateral Quadriceps Inhibition and Weakness After ACL Ruptures |
Prof. ONG Tim Yun 王添欣 |
| 2021.332 | A Double-Blinded, Randomized-Controlled-Trial to Investigate the Effect of Pulsed Electromagnetic Field (PEMF) for patients with quadriceps weakness after Anterior Cruciate Ligament Reconstruction (ACLR) |
Prof. ONG Tim Yun 王添欣 |
| 2021.491 | A Double-Blinded, Randomized-Control-Trial to Investigate the Effect of Pulsed Electromagnetic Field (PEMF) for Patients with Knee Osteoarthritis |
Prof. ONG Tim Yun 王添欣 |
| 2021.322 | Effect of Transcranial Direct Current Stimulation (tDCS) on Improving Inhibitory Control and Working Memory in Children with Attention-Deficit / Hyperactivity Disorder (ADHD) and comorbid Autism Spectrum Disorder (ASD) – A Randomised Controlled Trial |
Dr. OR Brian Parr Ning 柯栢菱 |
| 2015.086 | Bioimpedance spectroscopic detection of altered fluid status among elderly sub-acute congestive heart failure patients: an observational cohort study | Dr. OR Kevin Ka Hang |
| 2014.185 | Validation of ischemic stroke traditional Chinese medicine syndrome factor diagnostic scale (ISTCMDS) in Hong Kong | Dr. OR Kevin Ka Hang |
| 2017.523 | Validation of a clinical diagnostic instrument based on stroke patient records of Chinese medicine masters |
Dr. OR Kevin Ka Hang 柯加恆 |
| 2012.457 | A descriptive cohort study of stroke patients from sub-acute to chronic phase based on Ischemic Stroke TCM Syndrome Factor Diagnostic Scale | Dr. OR Kevin Ka Hang |
| 2007.464 | A Questionnaire Survey on Emergency Nurses' Competency after the Application of Mental Health Triage Tool | Ms OR Lai Chun Ikea |
| 2005.446 | 針刺曲池穴的即時降壓療效之臨床觀察 | OR Wai Leung William |
| 2025.913 | Comparative Real-world Effectiveness of Semaglutide vs Dulaglutide in Chinese Type 2 Diabetes Patients: A Retrospective Cohort Study at Tung Wah Hospital | Miss OR Wing Tung |
| 2025.168 | Hip neurolysis performed by anesthetists for patients unfit for surgery: A retrospective study in three acute hospitals in Hong Kong | Dr. OR Yin Ling |
| 2015.476 | Hope in the Context of Chronic Musculoskeletal Pain: Relationships of Hope to Pain and Psychological Distress |
Dr. OR Yin Ling 柯燕玲 |
| 2010.245 | Comparison of mearsuring subglottic airway diameter between 4D USG and standard MRI imaging in healthy adult volunteers | Dr Or Yin Ling |
| 2010.588 | The correlation between increased arterial stiffness and the 5-year probability of major clinical event generated from the risk engine JADE program | Dr. Ozaki Risa |
| 2025.767 | A retrospective review of patients with ectopic adrenocorticotrophic hormone (ACTH) syndrome in Hong Kong | Dr. OZAKI Risa |
| 2024.477 | Clinical Characteristics of Patient with Tumour Induced Osteomalacia in Hong Kong | Dr. OZAKI Risa |
| 2015.095 | A long term, randomised, double blind, placebo-controlled study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 diabetes mellitus Harmony Outcomes Trial | Dr. OZAKI Risa |
| 2015.195 | Insulin, Glucagon and Incretin Response to 75g Glucose Tolerance Tests: Comparison of Type 2 diabetes and healthy control among Asian Countries |
Dr. OZAKI Risa 尾崎麗莎 |
| 2014.450 | A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin® (pyridoxamine dihydrochloride) in Subjects with Nephropathy Due to Type 2 Diabetes (PIONEER) | Dr. OZAKI Risa |
| 2015.351 | An open-label, randomized, multi-center, single dose, two-period, two-sequence crossover study to investigate the bioequivalence of Peginterferon (PEG-IFN) alfa-2a benzyl alcohol-free formulation versus the reference market formulation following subcutaneous administration via prefilled syringe in healthy Chinese subjects |
Dr. OZAKI Risa Not applicable |
| 2014.425 | A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy - SONAR: Study Of Diabetic Nephropathy with Atrasentan | Dr. OZAKI Risa |
| 2014.366 | A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy | Dr OZAKI Risa |
| 2012.108 | A Phase III, multicentre, international, randomised, parallel group, double blind cardiovascular safety study of BI 10773 (10 mg and 25 mg administered orally once daily) compared to usual care in type 2 diabetes mellitus patients with increased cardiovascular risk | Dr. OZAKI Risa |
| 2011.152 | A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus | Dr. OZAKI Risa |
| 2010.347 | A 24-week, multi-center, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy and safety of vildagliptin 50mg bid as an add-on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus | Dr. Ozaki Risa |
| 2009.455 | Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) A Multicenter Randomized Double-Blind Placebo-Controlled Trial of a Thiazolidinedione or Placebo and of Vitamin D or Placebo In People With Type 2 Diabetes at Risk For Cardiovascular Disease | Dr. OZAKI Risa |
| 2014.010 | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 26-WEEK MULTICENTER STUDY WITH A 78-WEEK EXTENSION TO EVALUATE THE EFFICACY AND SAFETY OF ERTUGLIFLOZIN IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND INADEQUATE GLYCEMIC CONTROL ON METFORMIN MONOTHERAPY | Dr. OZAKI Risa |
| 2012.134 | A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ONCE-DAILY ADMINISTRATION OF A PHOSPHODIESTERASE 5 INHIBITOR (PF-00489791) IN ADULTS WITH TYPE 2 DIABETES AND OVERT NEPHROPATHY | Dr Ozaki Risa |
| 2010.345 | A phase III, randomised, double-blind, placebo-controlled, parallel group, efficacy and safety study of BI 10773 (10 mg and 25 mg administered once daily) as add on to pre-existing antidiabetic therapy over 52 weeks in patients with type 2 diabetes mellitus and renal impairment and insufficient glycaemic control | Dr. Ozaki Risa |
| 2009.212 | A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination with Metformin in Subjects with Type 2 Diabetes | Dr. Ozaki Risa |
| 2013.098 | A Multicenter Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145 | Dr Ozaki Risa |
| 2009.428 | Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration for the Treatment of Hyperglycemia in Metformin Monotherapy Treated Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study | Dr. Ozaki Risa |
| 2014.136 | Verifying Insulin Strategy and Initial Health Outcome Analysis (VISION) | Dr. OZAKI Risa |
| 2011.080 | A Phase III, Multicenter, Randomized, Open-label Clinical Trial Comparing the Efficacy and Safety of a Sitagliptin-Based Treatment Paradigm to a Liraglutide-Based Treatment Paradigm in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Monotherapy | Dr Ozaki Risa |
| 2013.293 | A randomized, double-blind, placebo-controlled, multi-center study to assess the safety and efficacy of different oral doses of BAY 94-8862 in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic nephropathy | Dr. OZAKI Risa |
| 2012.329 | A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of TAK-875 25 mg and 50 mg Compared to Glimepiride When Used in Combination with Metformin in Subjects with Type 2 Diabetes | Dr. OZAKI Risa |
| 2013.152 | A randomized controlled trial of a tailored intervention targeted smoking type 2 diabetic patients to promote smoking cessation and improve glycamic control | Dr. Ozaki Risa |
| 2011.029 | A Randomized, Double-Blind, Placebo-controlled, 3-Arm, Parallel-Group, 26-Week, Multicenter Study With a 26-Week Extension, to Evaluate the Efficacy, Safety and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment | Dr. Ozaki Risa |
| 2009.109 | A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination with Metformin Compared with Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects with Type 2 Diabetes Mellitus | Dr. Ozaki Risa |
| 2009.110 | A Randomized, Open-Label, Parallel-Group, Multicenter Study to Determine the Efficacy and Long-Term Safety of Albiglutide Compared With Insulin in Subjects With Type 2 Diabetes Mellitus | Dr. Ozaki Risa |
| 2008.322 | Combination Therapy of Insulin Glargine and Sitagliptin in Patients with Type 2 Diabetes Not Adequately Controlled by A Previous Treatment with Metformin and Either Insulin Glargine or Sitagliptin (EASIE Extension trial | Dr Ozaki Risa |
| 2008.321 | Superiority Study of Insulin Glargine Over Sitagliptin in Insulin-Na_ve Patients with Type 2 Diabetes Treated With Metformin and Not Adequately Controlled (EASIE Trial | Dr Ozaki Risa |
| 2010.344 | A phase III randomised, double-blind, active-controlled parallel group efficacy and safety study of BI 10773 compared to glimepiride administered orally during 104 weeks with a 104-week extension period in patients with type 2 diabetes mellitus and insufficient glycaemic control despite metformin treatment | Dr. OZAKI Risa |
| 2011.522 | A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Co-Administration of Sitagliptin and Atorvastatin in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin Monotherapy | Dr. OZAKI Risa |
Page 200 of 289.